[Form 4] Levi Strauss & Co. Insider Trading Activity

Rhea-AI Filing Summary

Christopher J. McCormick, a director of Levi Strauss & Co. (LEVI), reported awards and related contingent dividend-equivalent rights on 08/08/2025. The filing shows the acquisition of 213 dividend equivalent rights (DERs) tied to Class A Common Stock and 41 DERs tied to Class B Common Stock, both reported as acquired at a $0.00 price. After these transactions, the report lists 70,103 shares of Class A Common Stock and 57,464 shares (or equivalents) of Class A Common Stock underlying Class B holdings as beneficially owned directly. The DERs vest and settle consistent with underlying awards; unvested awards vest on the earlier of the day before the next annual meeting or one year after grant, and some DERs are fully vested but subject to deferred delivery.

Positive

• Reported increase in director holdings: acquisition of 213 Class A DERs and 41 Class B DERs recorded, raising reported beneficial positions.
• Clear vesting terms disclosed: DERs vest consistent with underlying awards and accelerate to vest by the earlier of the next annual meeting or one-year post-grant, ensuring defined settlement timing.
• Some DERs fully vested but subject to a deferred delivery feature, indicating the director has vested entitlements even if delivery is deferred.

Negative

• None.

Insights

Securities Analyst

TL;DR: Director McCormick acquired executive award-related DERs on 08/08/2025, modestly increasing his reported beneficial holdings.

The Form 4 documents grant-related activity rather than open-market trading. The acquisition of 213 Class A DERs and 41 Class B DERs at $0.00 reflects compensation settlement mechanics, not a cash purchase. Reported beneficial ownership totals of 70,103 (Class A) and 57,464 (underlying Class B) are explicitly stated and should be used for shareholding calculations. Impact on share count or signaling is limited absent sale or cash purchase details.

Corporate Governance Expert

TL;DR: This is routine disclosure of award settlements and vesting terms, with deferred delivery on some vested DERs.

The filing discloses vesting mechanics: DERs vest with underlying awards and unvested awards accelerate to vest by company meeting or one-year anniversary. Some DERs are fully vested but subject to a deferred delivery feature. The report is standard for executive/director compensation administration and raises no governance red flags based on the provided facts.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McCormick Christopher J

(Last) (First) (Middle)

C/O LEVI STRAUSS & CO.

1155 BATTERY STREET

(Street)

SAN FRANCISCO CA 94111

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LEVI STRAUSS & CO [ LEVI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/08/2025		A		213(1)	A	$0.00	70,103	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Class B Common Stock	$0.00(2)	08/08/2025		A		41(3)		(2)	(2)	Class A Common Stock	41	$0.00	57,464	D

Explanation of Responses:

1. Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and the related DERs vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Certain underlying awards are fully vested and are subject to a deferred delivery feature, these same terms apply to the related DERs.

2. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

3. Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature.

	/s/ Priscilla Duncan-Tannous, Attorney-in-Fact	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Christopher J. McCormick report on the Form 4 for LEVI?

The Form 4 reports the acquisition of 213 DERs tied to Class A Common Stock and 41 DERs tied to Class B Common Stock, both reported on 08/08/2025.

How many Levi Strauss shares does McCormick beneficially own after the reported transactions?

The filing lists 70,103 Class A shares beneficially owned and the Class B-related holdings equivalent to 57,464 Class A shares following the transactions.

What are DERs mentioned in the Form 4?

The filing defines DERs as dividend equivalent rights that represent a contingent right to receive one share of the issuer's Class A or Class B Common Stock upon settlement.

Are the reported DERs vested?

Some DERs are described as fully vested and subject to deferred delivery; unvested DERs vest on the earlier of the day before the next annual stockholder meeting or one year after grant.

When were the transactions and who signed the Form 4?

Transactions are dated 08/08/2025, and the form was signed by Priscilla Duncan-Tannous, Attorney-in-Fact on 08/12/2025.